Equity (Tables)

9 Months Ended

Jun. 30, 2020

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The effect of recording stock-based compensation expense was as follows:

	For the three months				For the nine months
Stock-based Compensation Expense - by award type	ended June 30,				ended June 30,
(in thousands)	2020		2019		2020		2019
Employee stock options	$	4	$	6	$	13	$	20
Restricted stock units and awards		403		380		1,331		1,162
Performance stock units and awards		255		188		910		357
Employee stock purchase plan		52		50		145		132
Outside director equity awards and fees in common stock		65		53		226		152
Total stock-based compensation expense	$	779	$	677	$	2,625	$	1,823

Schedule of Stock-based Compensation Expense - By Expense Type

	For the three months				For the nine months
Stock-based Compensation Expense - by expense type	ended June 30,				ended June 30,
(in thousands)	2020		2019		2020		2019
Cost of revenue	$	166	$	121	$	504	$	341
Selling, general, and administrative		488		367		1,564		999
Research and development		125		189		557		483
Total stock-based compensation expense	$	779	$	677	$	2,625	$	1,823

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted net loss per share:

	For the three months				For the nine months
Basic and Diluted Net Loss Per Share	ended June 30,				ended June 30,
(in thousands, except per share)	2020		2019		2020		2019
Numerator:
Loss from continuing operations	$	(1,287)	$	(10,477)	$	(7,703)	$	(21,009)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share		(1,287)		(10,477)		(7,703)		(21,009)
Denominator:
Denominator for basic and fully diluted net loss per share - weighted average shares outstanding		29,295		28,005		29,052		27,730
Net loss per basic and fully diluted share	$	(0.04)	$	(0.37)	$	(0.27)	$	(0.76)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation		1,410		1,317		1,316		881

Schedule of Common Stock Reserved for Future Issuances

As of June 30, 2020, we had common stock reserved for the following future issuances:

	Number of Common
	Stock Shares Available for
Future Issuances	Future Issuances
Exercise of outstanding stock options	44,976
Unvested restricted stock units and awards	1,630,273
Unvested performance stock units and awards (at 200% maximum payout)	1,752,000
Purchases under the employee stock purchase plan	428,349
Issuance of stock-based awards under the Equity Plans	850,861
Purchases under the officer and director share purchase plan	88,741
Total reserved	4,795,200